Srour M, Alsuliman T, Labreuche J, Bulabois CE, et al. Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplant 2023 Jan 9. doi: 10.1038/s41409-022-01898.
PMID: 36624161